Replimune Group, Inc. (REPL) is a publicly traded Healthcare sector company. As of October 22, 2026, REPL trades at $11.73 with a market cap of $1.08B and a P/E ratio of -3.89. REPL moved +0.09% today. Year to date, REPL is +20.58%; over the trailing twelve months it is +31.02%. Its 52-week range spans $1.50 to $16.33. Analyst consensus is strong buy with an average price target of $19.14. Rallies surfaces REPL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
REPL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. REPL recently traded at $11.73. Market cap is $1.08B. P/E ratio is -3.89. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $11.73 |
| Market Cap | $1.08B |
| P/E Ratio |
| -3.89 |
| EPS | $-3.38 |
|---|
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $16.33 |
|---|
| 52-Week Low | $1.50 |
|---|
| Volume | 26.25K |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $0 |
|---|
| Net Income | $-313.94M |
|---|
| Gross Margin | 0.00% |
|---|
8 analysts cover REPL: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.14.